semaglutide news Compounding pharmacies to halt sales May 22 Kids approved for weight loss

(2025, September 17)

DOI: Published online: July 24, 2025 1 Institute of Medical Research, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea 2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Correspondence to Seok-Woo Hong, PhD Institute of Medical Research, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea Email: [email protected] Won-Young Lee, MD Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea Email: [email protected] *Jinmi Lee and Eun-Jung Rhee contributed equally to this work as co-first authors

Distribution of glucagonlike peptide I (GLPI), glucagon, and glicentin in the rat brain: An immunocytochemical study

Subsequently, the study cohort was divided into exposure (i.e., patients who took GLP-1RA medications and no insulin) and comparison groups (i.e., patients who took insulin and no GLP-1RA medications)

NAD+ NAD+ (Nicotinamide Adenine Dinucleotide) is a critical coenzyme found in every cell of the body, involved in hundreds of metabolic processes

The reviews found little to no difference between the drugs and placebo when looking at major cardiovascular events, mortality, or quality of life